Wuhan YZY Biopharma Co Ltd (02496.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4Sep 9Sep 14

Key dataSep 14, 2026

OpenHKD 3.30

From 52W high−58.85%

Volume0.00

Market capHKD 639.70M

P/E (TTM)—

P/S (TTM)6.5x

Div yield—

Key dataSep 14, 2026

Open

HKD 3.30

From 52W high

−58.85%

Volume

0.00

Market cap

HKD 639.70M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−6.4x

P/E (TTM)

—

RSI (14)

1.2

MomentumView details →

1D Return

−8.33%

YTD Return

−58.85%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−6.4x

EV/Sales

6.8x

P/S (TTM)

6.5x

P/B (TTM)

−10.3x

ProfitabilityView details →

Gross Margin

16.27%

Net Margin

−114.69%

EBITDA Margin

−105.28%

ROE (TTM)

183.31%

ROA (TTM)

−55.54%

Asset Turnover

0.48x

GrowthView details →

Revenue YoY

−21.36%

EPS YoY

+4.28%

FCF YoY

+59.70%

Revenue CAGR 3Y

+206.46%

EPS CAGR 3Y

+16.00%

EBITDA YoY

+3.00%

MomentumView details →

1D Return

−8.33%

YTD Return

−58.85%

1Y Return

−43.10%

RSI (14)

1.2

vs 50D SMA

−7.50%

vs 200D SMA

−38.07%

Capital & dividendView details →

Debt/Equity

−2.41x

Current Ratio

0.66x

Quick Ratio

0.64x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

84.79M

Net Income (TTM)

−97.25M

Op. CF (TTM)

−39.98M

Latest newsMore news →

Youzhiyou Biologics announced a private placement of 35.5924 million domestic shares at RMB 2.43 per share to subscribers Yuan Qian, Zhou Hongfeng, and Zhou Pengfei, with net proceeds of about RMB 83 million, and the shares will resume trading on September 10.11d ago

Youshiyou Biopharmaceutical reported interim results for the six months ended June 2026, with revenue of 33.143 million RMB, down 10.9% year-on-year, and a narrowed net loss of 6.26 million RMB compared to a loss of 58.834 million RMB in the same period last year.23d ago

Similar companies

Brii Biosciences Limited02137.HK Neurogene Inc.NGNE Altimmune, Inc.ALT Monopar Therapeutics Inc.MNPR OmniAb, Inc.OABI Crescent Biopharma, Inc.CBIO Find similar companies →

Latest newsMore news →

Youzhiyou Biologics announced a private placement of 35.5924 million domestic shares at RMB 2.43 per share to subscribers Yuan Qian, Zhou Hongfeng, and Zhou Pengfei, with net proceeds of about RMB 83 million, and the shares will resume trading on September 10.11d ago Youshiyou Biopharmaceutical reported interim results for the six months ended June 2026, with revenue of 33.143 million RMB, down 10.9% year-on-year, and a narrowed net loss of 6.26 million RMB compared to a loss of 58.834 million RMB in the same period last year.23d ago